The Medicinal Potential of Mesenchymal Stem/Stromal Cells in Immuno- and Cancer Therapy

Mehdi Najar; Hassan Fahmi; Makram Merimi

doi:10.3390/biom13081171

The Medicinal Potential of Mesenchymal Stem/Stromal Cells in Immuno- and Cancer Therapy

Biomolecules. 2023 Jul 27;13(8):1171. doi: 10.3390/biom13081171.

Authors

Mehdi Najar^{1

2}, Hassan Fahmi², Makram Merimi³

Affiliations

¹ Faculty of Medicine, Université Libre de Bruxelles, 1070 Brussels, Belgium.
² Osteoarthritis Research Unit, Department of Medicine, University of Montreal Hospital Research Center (CRCHUM), Montreal, QC H2X 0A9, Canada.
³ LBBES Laboratory, Genetics and Immune Cell Therapy Unit, Faculty of Sciences, University Mohammed Premier, Oujda 60000, Morocco.

Abstract

Cancer is a highly lethal disease that causes millions of deaths worldwide, thus representing a major public health challenge [...].

Publication types

Editorial
Research Support, Non-U.S. Gov't

MeSH terms

Mesenchymal Stem Cells*
Neoplasms* / therapy
Public Health

Grants and funding

This work received support from the Generation Life Foundation, Fonds Lam-beau-Marteaux, Fonds National de la Recherche Scientifique (FNRS), Télévie, Les Amis de l’Institut Jules Bordet, La Chaire en Arthrose de l’Université de Montréal, The Arthritis Society (SOG-20-0000000046), and The Canadian Institutes of Health Research (PJT 175-1110). This work was supported by Le Centre National pour la Recherche Scientifique et Technique (CNRST) and L’Agence Nationale des Plantes Médicinales et Aromatiques (ANPMA), both located in Morocco.